Treatment of liver fibrosis using traditional chinese medicine through anti-inflammatory mechanism

投稿的翻译标题: 中医药的抗炎机制在治疗肝纤维化中的作用

Bo Li*, Wen Tao Feng, Jing Yi Li, Tian Mei Li, Yan Lu Cao, Fang Lü, Rong Ji Dai*, Yu Lin Deng*

*此作品的通讯作者

科研成果: 期刊稿件文献综述同行评审

6 引用 (Scopus)

摘要

Liver is the largest substantial organ in the abdominal cavity and it provides an essential role in maintaining the basic physiological functions. Liver diseases have become one of the common and frequently-occurring diseases that affect 10% of the population worldwide, usually with liver fibrosis as the late stage pathological characteristic. Due to the complexity of pathogenesis, there is no effective synthetic drug to treat liver fibrosis up to date. Traditional Chinese medicine (TCM) has the advantages of multiple targets and small side effects in the treatment of liver fibrosis. This article reviews the pathological mechanisms of liver fibrosis and its relationship with inflammation. The application of the active herbal ingredients in TCM, medicinal plants and traditional Chinese formulae to treat liver fibrosis, and their mechanisms of action to inhibit inflammation associated with liver fibrosis are also discussed.

投稿的翻译标题中医药的抗炎机制在治疗肝纤维化中的作用
源语言英语
页(从-至)790-808
页数19
期刊Progress in Biochemistry and Biophysics
47
8
DOI
出版状态已出版 - 2020

指纹

探究 '中医药的抗炎机制在治疗肝纤维化中的作用' 的科研主题。它们共同构成独一无二的指纹。

引用此